Upper Abdominal Pain © MedTx, LLC 2017

Disclaimer: Please note, this page is intended for strictly educational purposes. Potential future clinical use may be possible, however the content has NOT been sufficiently reviewed and therefore may not be relied upon.  This page may be used for educational purposed only and only in conjunction with a board certified physician who can appraise by visiting this page, you assume any and all risk. Please read full disclaimer page prior to continuing.
  • CC: year old with pertinent PMH/PSH presents with
  • Focused HPI
    • nb/nb vomiting
    •  hx of abd surgeries
    • Biliary related history:
      • hx of gallstones
      • recent fevers
      •  vomiting
      •  worse after eating
    • Ulcer risk factors:
      • hx of ulcers
      •  BRBPR/tarry stool
      •  hx of heavy etoh use
      •  hx of high dose/prolonged NSAIDS
    • no suspicious foods/sick contacts/recent travel
  •  HPI:
    • Characteristics obtain from interview with patient:
      • Quality of symptom:
        •  
      • Onset: 
        • acute, 
        • subacute, 
        • chronic, 
      •   Circumstances at time of onset:
        • pt unable to recall
      •   Since onset:
        • constant, 
        • intermittent, 
        • resolved, asymptomatic at this time, 
        • improving, 
        • worsening, 
      • Description of quality of symptom:
        • painful, 
          • sharp, 
          • dull, 
          • pressure, 
          • burning
      • Location:
      • Provocation:
        • none
      • Alleviation:
        • none, 
      • Associated symptoms
        • none
      • History of similar symptom is past
        • never
      • Outcome of symptom in past
      • History unfortunately limited
        • secondary
          • to patient"s condition, 
          • to requirement of emergent diagnostics/interventions that take precedence over extensive history, 
          • to patient"s lack of understanding of their medical conditions, 
          • to patient"s lack of cooperative with interview, 
          • to lack of medical records for this patient available in our system,
          • to lack of patient bringing medical information
    • Pertinent positives:
    • Pertinent negatives:
  • REVIEW OF SYSTEMS:
    • Much of this set of ROS can be generally obtained by asking: Are you sick now or recently sick? Any pain anywhere in your body other than what we spoke about? Any vomiting or changes in your bowel habits? Any bleeding from anywhere?
    • Constitutional:
      •  
      • fevers, 
      • rigors, 
    • ENT: 
      • rhinorrhea,  otalgia, sore throat
      • as noted in HPI
    • Eye:
      • vision grossly intact
      • as noted in HPI
    • Cardiac:
      • chest pain, 
      • LE swelling, 
      • no unilateral LE swelling
      • as noted in HPI
    • Pulmonary:
      • shortness of breath, 
      • cough, 
      • as noted in HPI
    • GI:
      • abdominal pain, 
      • nausea, 
      • vomiting, 
      •   BRBPR, dark tarry stool, 
      • diarrhea
      • as noted in HPI
    • GU:
      • no dysuria,
      • no discharge, 
        •  male specific:
          • no testicular pain, 
        • female specific: 
          • no abnormal vaginal bleeding, 
      • as noted in HPI
    • Neuro:
      • no recent severe headache outside of normal headaches per patient, 
      • no recent ALOC, 
      • moves all 4 extremities without any clear focal deficits,
      • Focused Neurological Exam:
        • CN II-XII intact,
        • vision grossly intact, 
        • PEERL, 
        • EOM intact, 
        • strength symmetric intact at major flexion and extension joints throughout UEs and LEs, 
        • no sensory deficits (per patient with light touch),
        • cerebellar function intact (finger-nose-finger), 
        • normal gait in ED,
        • no sensory deficit in GU region, 
        • able to squeeze buttock, 
        • normal rectal tone, 
      • as noted in HPI
    • MSK:
      • no recent trauma
      • no focal weakness, 
      • no pain in extremities or joints, 
      • as noted in HPI
    • Pysch:
      • normal speech, 
      • normal affect,
      • linear though process, 
      • no SI, 
      • no HI, 
      • appears able to care for self by evidence of being dressed, groomed, linear though processes expressed for history and plan after discharge, 
      • no AH, 
      • no VH, 
      • as noted in HPI
    • ID:
      • no recent antibiotics,
    • Endo:
      • no polyuria/polydipsia
      • as noted in HPI
  • EXAM:
    • VITALS: (overall impression of vital signs with repeat vitals in EMR as RNs re-assess patient):
      • HR:
        • normal HR.
        • tachyardic
      • BP:
        • normotensive.
        • hypertensive
          • (attempted to inform pt to advise to f/u with PMD).
          • hypotensive.
      • O2 sat:
        • no hypoxia
        • hypoxic
      • RR:
        • normal RR
        • tachypnic
    • PHYSICAL EXAM:
      • General:
        • well nourished
        • no distress
        • mild distress
        • moderate distress
        • severe distress
      • HEENT:
        • vision grossly intact.
        • hearing grossly intact.
      • Cardiovascular:
        • no r/m/g
        • no LE swelling
      • Pulmonary:
        • Lungs CBTA,
        • No respiratory distress,
        • Speaking comfortably in full sentences.
        • I/E wheezing,
        • rales,
        • rhonchi
        • respiratory distress,
      • GI:
        • abd soft,
        • abd non-tender in all 4 quadrants,
        • TTP diffusely
        • TTP in RUQ
        • TTP in RLQ
      • Neuro:
        • Normal LOC.
        • No grossly focal neurological deficits.
        • Somnolent through protecting airway
      • MSK:
        • no deformities,
        • moving all extremities
        • Non-ambulatory.
      • Psych:
        • Normal speech.
        • Demonstrates linear thinking.
        • No SI/HI.
        • Endorses SI
        • Endorses HI
        • Exam consistent with gravely disabled.
        • No AH/VH.
        • Agitated.
        • Confused.
  • Focus Exam (based upon chief complaint)
    • Abdominal Exam:
  • ED COURSE and MDM:
  • Diagnostically:
    • cbc (to eval for luekocytosis or significant anemia)
    • bmp (to eval for electrolyte derangements)
    • LFT’s, lipase (to eval for labratorial evidence of hepato-biliary pathology)
    • UA (to eval for atypical presentation of UTI/pyelo)
    • upreg
    • EKG (eval for atypical anginal presentation)
    • trop
    • RUQ US: no sonographic evidence cholecystitits
    • CT (indications: suspicion for acute surgical abdominal processes: appendicitis, SBO, complicated diverticulitis, perforated viscus, AAA)
  • Therapeutically:
    • analgesia/anti-emetics
  • Additional Diagnostics/Therapeutics
    • Diagnostically:
      • Point of Care Testing:
        • Pregnancy Test
          • negative
        • POC gluc
          • wnl
        • POC Hg
          • wnl
        • iStat
          • potassium wnl
          • hyperkalemia
          • no base deficit
        • lactate
          • wnl
      •  EKG (as interpreted by prelim ED):
        • Non-remarkable EKG. No evidence of ischemia. NSR, regular rate, normal intervals, no abnormal TWI, no ST elevation/depression.
        • Rate
          • normal,
          • bradycardic,
          • tachycardic,
        • ST-segment morphology:
          • TWaves:
            • No abnormal TWI,
            • Abnormal TWI,
            • Non-specific repolarization abnormalities,
            • No ST depression, ST depression,
            • No ST elevation, ST elevation but does not meet STEMI criteria, meets STEMI criteria and cath lab activated,
        • Comparison to prior:
          • Unchanged when compared to prior,
          • Attempted but no old EKG available for comparison,
          • ,
        • Summary to pt"s clinical condition:
          • Normal EKG - not suggestive any pathology elucidated on EKG, Non-specific repolarization abnormalities - no definitive evidence of active ischemia on EKG, Evidence on EKG concerning for active ischemia.
        • Rhythm: 
          • Regularly regular: 
            • NSR,
            • Sinus tachycardia,
            • Sinus bradycardia,
          • Irregularly irregular:
            • Atrial fibrillation with normal ventricular rate,
            • Atrial fibrillation with RVR,
          • Regularly irregular:
            • tachycardic,
              • Atrial flutter with RVR,
            • bradycardic,
              • Heart block,
                • Type: ,
        • Intervals:
          • Narrow QRS,
            • supraventricular:
              • irregular:
                • AVRT (considering pre-excitation, considering WPW, etc), 
                  • Tx: Procainamide (20-50mg/min until arrhythmia suppressed, hypotension, QRS duration >50%, or max 17mg/kg. Maintenance 1-mg/min. 
                  • Tx: Synchronized cardioversion.
                    • Per ACLS 120-200J.
              •  regular: 
                • AVNRT (considering supraventricular tachycardia), 
                  • Tx: Adenosine 6mg IV push,
                    • Refractory, therefore second dose 12mg IV push 
                  • Synchronized cardioverson.
                    • 100 J
                    • per ACLS for narrow regular 50-100J
          • Wide QRS,
            •  bradycardic:
              •  low junctional escape/ventricular origin,
            • tachycardic:
              •  regular:
                •  stable,
                  •  Amiodarone 150mg IV / 10 min
                    •  Refractory, repeated PRN recurrence of VT. 
                    •  Maintenance 1mg/min x 6 hrs.
                  •  Procainamide (20-50mg/min until arrhythmia suppressed, hypotension, QRS duration >50%, or max 17mg/kg. Maintenance 1-mg/min. 
                  • synchronized cardioversion
                    •  100 J (per ACLS)
                •  unstable:
                  •  with pulse. Therefore Unstable Ventricular Tachycardia with Pulse. 
                    •  Synchronized cardioversion (per ACLS 100J).
                •  pulseless. Therefore pulseless ventricular tachycardia. ACLS initiated: (CPR. Defibrillation 200 J Biphasic. Epi 1mg. Continuation of ACLS.) 
      • Labs:
        • Ordered, pending at this time, including:
          • CBC, 
          • BMP, 
          • LFTs/lipase, 
          • UA, 
          • Urine Cx
          • lactate
          • Blood Cx
            • x2
          • CK, 
          • EtOH level, 
          • Ingestion labs (acetaminophen, ASA), 
          • Troponin, 
          • Delta troponin, 
          • BNP, 
          • HIV, 
          • Influenza, 
          • Urine toxicological screen, 
          • CRP,
          • ESR,
        • Reviewed and interpreted/correlated to clinical scenario to inform diagnosis and plan by me.  
          • No significant labratory abnormalities contributory to patient"s presentation.
          • Non-emergent abnormalities which I informed the patient about and advised for prompt outpatient follow up for outpatient care.  
          • Specifically: 
          • CBC:
            • No significant unexpected anemia, No significant leukocytosis, No thrombocytopenia.
            • Hg
              • anemia,
                • transfusion indicated given
                  • symptomatic
                  • < 7 Hg (6-8 range from restrictive transfusion strategy)
                  • active significant bleeding
                • transfusion not indicated (considered)
                • peri-baseline,
                • significantly lower than baseline
                • unknown baseline,
                • suspected iron deficiency contributory, will advise/rx Ferrous sulfate 325mg daily w/ vit C.
            • wbc"s
              • luekocytosis
                • suspect demarginalization given lack of infectious findings on hx/exam,
                • suggestive of infectious process, 
                • concerning for malignancy, advised to for follow up
              • leukopenic
                • neutropenic 
                  • ((ANC < 500))
            • platelets:
              • thrombocytopenic 
                • ((platelets < 150k))
                • transfusion not indicated
                  • given suspected consumptive process 
                  • ((ITP, TTP, HIT))
              • transfusion indicated given
                • <10 k (regardless that pt is asymptomatic)
                • <20k and and planned CVP or pt febrile
                • <50k and planned LP or neurosurgical procedure
            • pancytopeniac
              • likely 2/2 chemo
              • likely 2/2 HIV
              • likely 2/2 hep C
              • unclear etiology, will initiate eval w/ completion of eval and monitoring/treatment to be continef as outpatientafter ED
          • BMP:
            • No significant pathologic electrolyte derangements.
            • AKI, 
              • 50% increase from baseline
              • BUN/Cr >20 suggestive of prerenal process, 
                • will administer IVF
                • and recheck
            • CKD, 
              • grossly unchanged from prior, 
            • Hyperkalemia, 
            • Anion gap 
              • ((> 12))
            • acidotic suggested by low bicarb, 
          • LFTs/lipase:
            • No laboratory evidence of hepato-biliary pathology.
            • Transaminitis without elevated bilirubin, suggestive of hepatic pathology
            • Elevated direct bilirubin suggestive of biliary pathology
            • Elevated indirect bilirubin suggestive of increased rbc breakdown
          • UA:
            • Not consistent with urinary tract infection.   
            • Urine Cx sent with follow mechanism in place
            • Equivocal for infection
              • Empirically treated.
              • UCx sent with f/u mechanism in place
          • Cardiac Labs:
            • Troponin: 
              • undetectable
              • <99th percentile
              • >99th percentile but under cut off for positive
              • positive
              •  
            • Delta troponin
              • pending, pt under care of other service at time of delta troponin, 
              • undetectable, 
              • <99th percentile, 
              • >99th percentile but under cut off for positive, 
              • positive, 
              •  
            • BNP:
              • please note that greater than 500 suggests CHF, under suggests not CHF
              • not suggestive of CHF exacerbation
              • suggestive of CHF exacerbation
              • non-diagnostic
          • HIV:
            • negative,
            • positive, 
              • I discussed this finding with patient in sensitive private manner, educated on treatment options, offered resources, answered all questions, advised to have partner evaluated and advised to refrain from any of the common modes of transmission. 
            • Prior to test sent, pt was informed that we advise for testing for HIV. Pt did not opt out. 
          • Influenza
            • negative
          • CK: 
            • significantly elevated, requires trending,   usually for >500-1000k
            • mildly elevated, not anticipated to rise given negated precipitant, 
            • not high enough to suggest concern for pathology, 
          • Ingestion labs: 
            • acetaminophen
              • non-detectable, 
            • ASA:
              • non-detectable,
            • etoh
              • non-detectable, 
              • positive
          • Urine toxicological screen:
            • negative
            • postive for
          • Markers of inflammation
            • CRP suggestive of more acute inflammation
              • wnl
              • elevated
            • ESR suggestive of more chronic inflammation
              • wnl
              • elevated
      • Radiographically:
        • CXR:
          • Normal study: no tracheal deviation, non-widened mediastenum, normal cardiac boarder, no pleural effusion, no air under diaphragm, no focal consolidation, no PTX, no gross bony abnormalities.
          •  Pulmonary edema,
          •  Cardiomegaly,
          •  lobar opacity,
          • diffuse radio-opacities
          • pneumothorax
            • on right
            • on left
            • mediastenium midline
            • (This is an ED prelim radiographic interpretation in order to increase chance of finding obvious emergent pathology which can be intervened upon and to minimize delay in care secondary to delay of radiology to be able to provide formal reads. Given these studies require board certified radiologists to review and formal reads are beyond the scope of Emergency Medicine, institutional protocol in place which will alert current care team/patient for over-reads/changes/critical reads).
        • PXR (Pelvic XR):
          • no evidence of pelvic fracture
          • no evidence of hip fracture
          • appreciate limited sensitivity of PXR and therefore correlated clinically
        • XR of extremity
        • Advanced Imaging:
          • CT head:
            • negative for acute intra-cranial pathology
          • CT c-spine
            • negative for acute cervical neck pathology
          • CT chest
            • PE protocol
              • negative for PE
            • angio
              • negative for aortic dissection
          • CT a/p
            • w/ contrast,
            • non-con,
            • negative for acute intra-cranial pathology
          • CT of extremity:  
            • with venous contrast:
            • with arterial contrast:
            • non-con:
      • Consultations:
        • Discussed case with of the service who kindly recommended
        • Discussed case with who kindly agrees to come evaluation patient and provide recommendations. 
        • Obtained the collateral information to assist in ED care for patient 
          • advises
        • Time of consultation:
    • Therapeutically:
      • Empirically:
        • Anti-platelet agent: ASA
          • Empirically administered given ddx includes ACS and potential benefit outweighs potential harm
          • 162mg PO chewed
          • 325mg PO chewed
        • IVF
          • 30 cc/kg, 
          • 250cc, 
          • 500cc, 
          • 1 L, 
          • 2 L, 
        • Analgesia: 
          • acetaminophen,  
          • ibuprofen, 
          • hydrocodone/acetaminophen (pt informed not to drive/drink/take fall precautions/not make significant decisions for remainder of day)
          • morphine, 
          • ketorolac, 
          • hydromorphone
          • haloperidol (haldol)
            • indication:
              • sx refractory to other analgesia,
              • side effect profile of opioids likely to exacerbate symptoms, 
            • 3mg
              • IV 
              • IM 
            • 5 mg
              • IM 
              • IV 
            • 10mg
              • IM 
        • Anti-emetics
          • ondansetron (zofran), 
            • IV, 
            • ODT oral dissolving tablet
          • metoclopramide (reglan), 
            • 5 mg, 
            • 10mg, 
            • PO, 
            • IV, 
            • IM, 
          • lorazepam,
            • indication: 
              • prolonged QTC make risk of other similar medications that would prolong QTC prudent to avoid, 
              • sx refractory to other anti-emetics, 
          • haloperidol (haldol)
            • indication:
              • sx refractory to other anti-emetics, 
              • pain refractory to other analgesia, 
              • suspected to have quality of component of pain that may benefit from analgesic effects, 
            • 3mg
              • IV 
              • IM 
            • 5 mg
              • IM 
              • IV 
            • 10mg
              • IM 
        • Anxiolytic
          • lorazepam
            • 0.5 mg
            • 1 mg
            • 2mg 
            • PO
            • IV
            • IM
      • Anti-biotics: 
        • Timing: 
          • administered as promptly as source identified with sufficient likelihood to inform appropriate antibiotics (goal directed)
          • administered when source identified
          • administered within 1 hrs from triage
          • administered within 3 hrs from triage
        • Regimen:
          • ceftriaxone 1 g IV
          • ceftriaxone 1g IV / azithromycin 500mg IV
          • vancomycin IV / cefepime 1 g IV /  azithromycin 500mg IV
          • ceftriaxone 1g IV / metronidazole 500mg IV
          • Unasyn
          • vancomycin / zosyn
          • cefazoline (ancef) 1 g IV
  •   Assessment/Plan:
    • year old with PMH/PSH of
    • presented with
    • evaluation is most consistent with
    •  Concurrent evaluation for secondary problem is consistent with
    • DDx includes but in not limited to (pt does not meet reasonable likelihood/consistency with the dx to warrant additional pursuit of these entities (risks outweigh benefits of non-indicating testing)
      • Hepato-Biliary:
        • -Doubt cholecystitis given US shows no sonographic e/o cholecystitis and labs not concerning for cholecystitis. Pt advised if worsening of symptoms to return given possibility of interval development of cholecystitis.
        • -Doubt cholelithiasis given US shows no gall stones, normal LFTs.
        • -Doubt pancreatitis given lipase wnl.
      • GU:
        • -Doubt atypical presentation for nephrolithiasis given no CVA tenderness, no hematuria on UA.
        • -Doubt pyleonephritis given no CVA tenderness, non-infectious UA systemically well.
      • Gyn:
        • -Doubt pregnancy related complications (e.g. ectopic, abruption, etc) given upreg neg.
        • -Doubt PID given location of pt’s complaints in upper quadrants and pt denies high risk sexual history and denies vaginal discharge.
        • -Doubt ovarian torsion given abd pain is in upper quadrants which would be exceedingly atypical for primary ovarian pathology.
      • GI:
        • -Considered gastritis (infectious or ulcerative). Pt advised to f/u with PMD and if sx persist, to request GI referral for endocscopy for definitive diagnosis. Given possibility of gastritis/ulcer and relatively benign side effect profile, pt offered to start empiric trial of famotidine (OTC).
        • -Doubt bleeding ulcer given no hx of BRBPR/melena, no signs of anemia on exam nor significant anemia on cbc.
        • -Doubt perforated viscus given abd exam benign, pt well appearing, no significant labratorial abnormalities, non-severe pain, and tolerance of PO challenge in ED.
        • -Atypical for appendicitis and given low pre-test probability based upon hx, exam, risks of radiation related malignancy outweigh potential benefits of CT.
        • -Doubt diverticulitis given location of pain in upper quadrants.
        • -Doubt incarcerated hernia given no hernia on exam, no tender/non-reducible hernia on exam.
      • Endocrine:
        • -Doubt DKA given no elevated glucose with anion gap.
        • Vascular:-Doubt AAA given age, risk factors, no palpable pulstile mass, and atypical presentation for AAA.
    • Plan:
  • Re-evaluation:
    • Unchanged on re-evaluation. 
    • Improved on re-evaluation.
      • On thorough re-evaluation, after patient was observed on telemetric monitoring, patient remains hemodynamically stable, normal vital signs, with clear sensorium, repeat cardio-pulmonary-abdominal exam benign, is ambulatory, has no new development of pain, pain is well-controlled and is amenable to discharge after observation period in the ED.
      • Normal neurologically evaluation,   
        • Patient has normal speech, clear sensorium, exhibits linear thinking, able to articulate plan for aftercare, and exhibits normal fine motor skills.
        • Abdominal Benign. Repeat abdominal exam  did not reveal any tenderness in any of the four quadrants. No rebound their guarding. patient  tolerated PO fluids and food to the emergency department without any recurrence of abdominal pain or vomiting.
      • Respiratory status, 
        • No signs of respiratory distress on exam, able to speak in full sentences without dyspnea. Respiratory related vital signs reassuring and suggestive of improvement. Improved respiratory exam compared to prior.
        • Unchanged respiratory status compared to prior.
        • Worsening respiratory status compared to prior.
      • Clinically Sober.
        • Patient demonstrates clinical sobriety.
          • speak non-slurred speech
          • is alert and oriented
          • ambulatory with steady gate
          • has fine motor intact
          • able to articulate plan for safe aftercare upon discharge from ED.
        • Re-evaluation after sobriety did not reveal any new symptoms/signs. Unlikely initially unappreciated pathology on initial eval given patient has no new complaints and re-examination does not reveal any new abnormalities suggestive of previously undetected pathology.
        • Instructed patient to exercise cautions after discharge
          • Expressed the importance to the patient not drive for remainder of day and to exercise extreme caution while around stairs, areas for potential falls, and to avoid areas with potential for being hit by car (street crossing, etc). Patient advised not to drink/use substances which alter mental status/cause sedation/impair judgement or reflexes (alcohol, illicit substances, prescription medications) if driving in general and advised to refrain from those substances in general. Patient advised to seek treatment for substance abuse.
        • Patient requests discharge, will oblige demonstration of capacity, sobriety, and no unevaluated pathology.
    • On re-evaluation, remains intoxicated. Hemodynamically stable. Will continue observation.
  • Supplemental Documentation:
    • OBSERVATION NOTE:
      • Total observation time
      • Start of observation time
      • End of observation time
      • Decision for disposition made after observation. Disposition to
      • Observation performed in order to attempt to safely preclude an inpatient admission.
      •    Observation was performed given
        • diagnostic uncertainty (i.e. serial examinations and assessments by me to elucidate likelihood of a pathologic process).  
        • to determine intensity therapy required (i.e. there was a reasonable possibility that by observing the patient"s response to therapy, an admission may be abated and safely discharged). 
      • Observation by me in ED.
      • The observation was utilized as the primary diagnostic tool during that time.
      •   Of note, additional history was obtained at this time and there was no family history contributory to the patient"s current condition. 
      • Given patient had initial complaint concerning for significant deterioration resulting in severe morbidity and potential mortality, patient required direct observation and monitoring in the emergency department with trending of vital signs, telemetric monitoring reviewed by me, frequent reassessments by nursing with communication with me of status, re-accessments in addition by me, which were all required for patient"s safety during that time (monitoring while administering medications with risk for CNS/cardiac/pulmonary adverse reactions) and to determine patient"s disposition by assessing for response to interventions/treatment. Patient was observed under my supervision.
      • Revenue code: 0762.  HCPCS Code G0378
    •  CRITICAL CARE PROCEDURE NOTE:
      • Authorized and performed by: Attending physician
      •  Total critical time:
        • minutes.
          • CPT Code
      • Indication for critical care including pt has exhibited risk factors for and symptoms and signs concerning for impending deterioration included compromise of
        • airway,
        • respiratory stability,
        • cardiovascular collapse,
        • CNS irreversible damage,
        • metabolic derangements
        • renal failure
        • fulminant hepatic failure
      • PRIMARY DIAGNOSIS:
        • ((primary diagnosis must be one of these for critical care time to be documented))
      • Due to patient having a presentation that is concerning for a potentially pathologic process causing an resulting in significant morbidity and potential mortality, the patient required emergent evaluation in the emergency department including emergent diagnostics, emergent assessment and evaluation, and emergent and directed treatment in order to mitigate risk for life-threatening deterioration. The critical care time as indicated above included discussing history with patient, examining patient, interpreting vital signs including pulse oximetry, initiating and interpreting diagnostics, and clinical acumen in order to synthesize patient"s presentation to develop treatment plan and emergently implement the requisite steps. This part of my care the patient is exclusive of other billable procedures, specifically procedures, treating other patients, and any educational time. Please refer to the above rationale for further documentation regarding the critical nature of the patient during my care.
      • This critical care time is separate from teaching or other separately billable procedures or treating other patients.
    •  COUNSELING:
      • Patient/family educated to the extent possible in terminology matched to their understanding on diagnostics, assessment, and treatment plan along with the risks inherent to the diagnostics and therapeutics and plan. Patient/family amendable and in agreement with above plan. All questions and concerns addressed and answered.
      • Attempted shared decision making in discussion with patient/family in all circumstances where feasible and possible.
      • Attempted to explain and obtain patient"s approval for plan however unable to do so secondary to patient"s condition and the requirement of emergent evaluation and interventions.
    • SUPERVISION:
      • Discussed with attending.  Obtained approval/confirmation of evaluation (history, exam, diagnostics) and plan (assessment, interventions, disposition) with ED attending physician
      •  Evaluated patient with resident physician. I have evaluated the patient and discussed the patient"s history, exam, diagnostics, and plan with the resident physician and agree with plan as stated by resident physician.
    • Of note, follow up over-read mechanism in place for over-reads and follow up of pending diagnostics.